Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07481032
Eligibility Criteria:
Inclusion Criteria:
* Voluntarily signed informed consent form
* Aged 18-65 years
* Traditional Chinese Medicine (TCM) syndrome type: Qi-zhi -xue-yu
* Meeting the diagnostic criteria for hepatitis B-related cirrhosis
* aMAP score \> 60
Exclusion Criteria:
* \[Previously diagnosed with or treated for hepatocellular carcinoma (HCC) or other malignancies
* Pregnant or lactating women
* Decompensated cirrhosis (e.g., presence of obvious ascites, hepatic encephalopathy, or gastrointestinal bleeding)
* Concomitant liver diseases, including but not limited to hepatitis C virus infection, human immunodeficiency virus infection, alcoholic liver disease, autoimmune liver disease, or drug-induced liver injury
* Severe cardiac, renal, respiratory, or hematopoietic system diseases
* Determined by the investigator to be unsuitable for participation in this trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07481032
Study Brief:
Protocol Section:
NCT07481032